Randomized clinical trial to evaluate an e-health intervention for fear of cancer recurrence, anxiety, and depression among cancer survivors.

Authors

null

L. I. Wagner

Northwestern University, Chicago, IL

L. I. Wagner , J. Duffecy , K. A. Lehman , S. D. Sanford , M. Begale , E. Nawacki , D. C. Mohr

Organizations

Northwestern University, Chicago, IL, Northwestern University Feinberg School of Medicine, Chicago, IL

Research Funding

NIH

Background: Fear of cancer recurrence is a universal experience among survivors and for many, fear persists years after treatment completion. Psychosocial interventions to teach strategies for managing these fears would improve quality of life, yet barriers to accessing psychosocial care exist. Internet-based approaches to deliver psychosocial interventions can overcome these barriers. E-health interventions disseminate standardized intervention content using a medium that is widely accessible and relatively inexpensive. Incorporating a social networking feature may improve e-intervention adherence through facilitating peer support. The purpose of this study is to evaluate an innovative e-health intervention +/- social networking to reduce fear of recurrence, depression, and anxiety among cancer survivors. Methods: Eligibility criteria include 1) any cancer diagnosis (excluding basal or squamous cell skin cancers), 2) completed cancer treatment and in remission, with no evidence of disease or stable disease, 3) ECOG performance status 0-2, 4) at least 19 years of age, 5) no history of psychiatric hospitalization in the past 5 years and 6) not currently receiving psychosocial treatment. Participants are randomized by group into one of two conditions: e-health intervention versus e-health intervention + social networking component. The e-health intervention is an interactive website with 8 weeks of didactic material based on empirically supported cognitive behavioral strategies and tools to facilitate application of coping strategies. Optional modules teach behavioral management strategies for fatigue, pain, sleep disturbance, cognitive dysfunction and body image concerns. The social networking feature includes structured interactions with cancer survivors randomized to the same group. Outcome measures include the Concerns about Recurrence scale, Hospital Anxiety and Depression Scale, adherence to the intervention (website utilization) and EQ-5D to evaluate cost effectiveness. To date, 31 participants have been randomized: e-health intervention only (two groups, n = 8 per group), e-health + social networking (two groups, n = 6 and 9).

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2011 ASCO Annual Meeting

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session

Track

Special Sessions,Clinical Trials

Sub Track

Quality of Life Mgmt

Clinical Trial Registration Number

NCT01114802

Citation

J Clin Oncol 29: 2011 (suppl; abstr TPS237)

Abstract #

TPS237

Poster Bd #

53C

Abstract Disclosures

Similar Abstracts

First Author: Khalid Y. Alkhatib

Abstract

2023 ASCO Genitourinary Cancers Symposium

Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.

First Author: Tyler J. Nelson

Abstract

2020 ASCO Virtual Scientific Program

CIFeR: A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors.

First Author: Jia Liu